Rosuvastatin Completed Phase 3 Trials for Type 2 Diabetes Mellitus / Dyslipidemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02126358Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)
NCT02586129Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
NCT02827903Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia